Sofi Stock Slides as Director Sells Shares and Valuation Flags Rise
sofi stock has fallen in recent sessions as investor concern mounted after a director sale and fresh valuation work that suggests the shares may be priced above intrinsic value. The moves come amid a cluster of corporate and market signals that have pushed the shares lower into late February and early March.
Sofi Stock on the Move After Director Sale
The stock recorded notable selling pressure in late February, trading down by -7. 43 percent as of early March, with a close of $17. 68 on Feb. 27, 2026 and a recent intraday peak near $19. 18 a few days prior. A company director, Steven J Freiberg, sold 94, 225 shares in the period, netting $1, 913, 710, while retaining control of more than 588, 849 common shares.
Valuation Signals Point to Possible Overvaluation
Valuation analysis using an Excess Returns model produced an intrinsic value of about $13. 01 per share, while the share price was cited at around US$17. 76, implying the stock could be roughly 36. 5% overvalued on that framework. The same analysis lists a Book Value of $8. 26 per share, a Stable EPS of $0. 88 per share (based on weighted estimates from eight analysts), an Average Return on Equity of 9. 93% and a Cost of Equity of $0. 69 per share, producing an Excess Return of $0. 18 per share and a Stable Book Value of $8. 85. The company also scored 0 out of 6 on a standard valuation checklist used in the model.
Performance Trends and Financial Backdrop
Price moves have been sharp: a 6. 6% decline over seven days, a 27. 8% drop over 30 days and a 35. 3% decline year to date, though the stock still showed a 22. 7% return over a one-year window. On the operational side, three-year and five-year revenue growth rates were cited at 29. 21% and 49. 24%, respectively, while recent metrics flagged negative EBIT, EBITDA and pre-tax profit margins and negative returns on assets and equity. Total assets were listed at $50. 66 billion, with a debt-to-equity ratio of 0. 18 and negative free cash flow; analysts also noted dilution tied to $3. 2 billion in capital raises and a CFRA reiteration of a Hold rating.
